Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-096603

Insys Therapeutics, Inc. · INSY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 5, 2016
Accepted (ET)
Feb 9, 2016 · 2:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 5, 2016M8,500$13.57A8,500D
Common StockFeb 5, 2016M9,500$3.63A18,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F3,F1,F2$13.57Feb 5, 2016M8,500D—Aug 6, 2024Common Stock8,5009,500D
Stock Option (right to buy)F6,F4,F5$3.63Feb 5, 2016M9,500D—May 13, 2023Common Stock9,50050,500D

Explanation of responses